close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar50Point36
Implied share price

Sell Overvalued by 38.0%

5% margin of safety What's this?

EV / EBITDA
Use Average
LLY
Eli Lilly & Co.
JNJ
Johnson & Johnson
Change
NVS
Novartis AG (ADR)
Change
PFE
Pfizer Inc.
Change
MRK
Merck & Co., Inc.
Change
11.78 18.58 12.21 13.2 11.9 9.04
All amounts in millions
from last financial year
         
Implied Share Price $50.36 $114.02 $71.56 $33.90 $82.09
Market Cap 89,731 322,696 212,603 207,930 171,277
Net Debt 3,526 -18,515 16,599 15,609 12,985
Enterprise Value (EV) 93,258 304,181 209,620 223,539 184,261
Revenue 19,958 70,074 50,359 48,851 39,498
EBITDA 5,019 24,918 15,880 18,788 20,379
Percent 25.2 % 35.6 % 31.5 % 38.5 % 51.6 %
EBIT 3,592 21,172 10,655 13,631 14,004
Percent 18.0 % 30.2 % 21.2 % 27.9 % 35.5 %
Balance Sheet          
Total Assets 35,568 133,411 131,556 167,381 101,677
Total Liabilities 20,997 62,261 54,510 102,661 57,001
Shareholders Equity 14,571 71,150 77,046 64,720 44,676.0

Price history

Comments

No comments yet. Login to comment.